ARRB1 & ARRB2 Knockout HEK293T Cell Line

The choice depends on whether you are studying combined β-arrestin 1/2 functions or modeling biased GPCR agonism. The Double Knockout line is the gold-standard tool for asking whether β-arrestins are required for GPCR functions — ARRB1 (β-arrestin 1) and ARRB2 (β-arrestin 2) are highly homologous scaffold proteins that bind agonist-occupied phosphorylated GPCRs, mediating receptor desensitization, internalization, and G-protein-independent signaling (ERK, p38, JNK activation through β-arrestin-MAPK scaffolding). Combined β-arrestin 1/2 double knockout eliminates β-arrestin-mediated signaling, enabling pure G-protein-only GPCR analysis. For GPCR pharmacology research, the EDITGENE ARRB1 & ARRB2 Double Knockout in HEK293T is the gold-standard genetic tool — HEK293T's very high transfection efficiency supports systematic biased agonism research. Single β-arrestin paralogs share substantial functional overlap — double knockout completely eliminates β-arrestin-mediated functions. Single-isoform rescue (ARRB1 alone or ARRB2 alone) enables paralog-specific functional dissection — gold-standard experimental design. The double knockout is uniquely valuable for studying ⭐⭐ biased GPCR agonism (G-protein-biased vs β-arrestin-biased ligands), GPCR-targeted drug development with biased activation profiles (TRV027 angiotensin biased, oliceridine/Olinvyk biased μ-opioid), and emerging biased GPCR therapeutics.

Primary applications: • Biased GPCR agonism: parallel G-protein vs β-arrestin signaling analysis given pure G-protein-only GPCR pharmacology in the double KO. • Single-isoform rescue: re-introduction of ARRB1 alone or ARRB2 alone enables paralog-specific functional dissection — gold-standard experimental design. • GPCR internalization: agonist-induced receptor internalization analysis — abolished in β-arrestin-null cells. • Biased ligand specificity: critical genetic control for ⭐ oliceridine (Olinvyk, FDA-approved G-protein-biased μ-opioid), TRV027 (β-arrestin-biased angiotensin), and emerging biased GPCR drug development. EDITGENE recommends this HEK293T-based double KO as the gold-standard genetic tool for biased GPCR pharmacology and biased ligand drug development.

Yes, and rescue experiments are uniquely powerful in this double knockout for biased GPCR research: • Single-isoform rescue: re-introduction of ARRB1 alone or ARRB2 alone enables paralog-specific functional dissection — gold-standard experimental design for β-arrestin paralog biology. • Construct design: use codon-modified ARRB1 or ARRB2 sequences with small C-terminal tags (FLAG, HA) — small tags preserve β-arrestin conformational changes. • Phosphorylation-independent mutant rescue: R169E (β-arrestin 1) or analogous mutations generate phosphorylation-independent active β-arrestin for biased agonism research. • Functional readout: rescue should restore agonist-induced GPCR internalization and β-arrestin-mediated MAPK signaling. HEK293T transduces with very high efficiency and supports systematic isoform-specific rescue experiments.